Gene · 2739
Papers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,767
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retraction Note: Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB. | Br J Cancer | 2025 | 40307440 | PubTator, text mining | PubMed |
| Flavonoids in Lotus Stamen Extract Inhibit High Glucose-Induced Intracellular Glycation in Fibroblasts by Upregulating the Expression of Glyoxalase 1 and Alleviating Oxidative Stress. | Antioxidants (Basel) | 2025 | 40298628 | PubTator, text mining | PubMed |
| Elevated Methylglyoxal: An Elusive Risk Factor Responsible for Early-Onset Cardiovascular Diseases in People Living with HIV-1 Infection. | Viruses | 2025 | 40284990 | PubTator, text mining | PubMed |
| Metolazone and Azosemide, Clinically Utilized Diuretics, Exhibit Inhibitory Activity for Glyoxalase I. | Biotechnol Appl Biochem | 2025 | 40200695 | PubTator, text mining | PubMed |
| Protein post-translational modification crotonylation of TXN and GLO1 in artery and vein grafts for coronary artery surgery. | Redox Biol | 2025 | 40138913 | PubTator, text mining | PubMed |
| It's a small world: Sinningia double flower cultivars share the same GLOBOSA1 allele. | Plant Cell | 2025 | 40048697 | PubTator, text mining | PubMed |
| Simplified and economic measurement of glyoxalase I activity using 2,4-dinitrophenylhydrazine: A valuable tool for researchers. | Biol Methods Protoc | 2025 | 40040836 | PubTator, text mining | PubMed |
| Dynamic investigation of hypoxia-induced L-lactylation. | Proc Natl Acad Sci U S A | 2025 | 40030031 | PubTator, text mining | PubMed |
| Glo1 reduction in mice results in age- and sex-dependent metabolic dysfunction. | bioRxiv | 2025 | 39896461 | PubTator, text mining | PubMed |
| Itaconate drives pro-inflammatory responses through proteasomal degradation of GLO1. | Biochem Biophys Res Commun | 2025 | 39787788 | PubTator, text mining | PubMed |
| Exogenous Treatment of Caffeic Acid and Methylglyoxal Synergistically Enhances Anticancer Effect in Prostate Cancer via Inhibition of Glyoxalase-1. | Prostate | 2025 | 39748483 | PubTator, text mining | PubMed |
| Unveiling the substantial role of rutin in the management of drug-induced nephropathy using network pharmacology and molecular docking. | Int Immunopharmacol | 2025 | 39733639 | PubTator, text mining | PubMed |
| A Mediterranean diet improves glycation markers in healthy people and in those with chronic diseases: a systematic review of clinical trials. | Nutr Rev | 2025 | 38719207 | PubTator, text mining | PubMed |
| Blue light stimulated-autofluorescence green flash of lysosome-related organelles in the intestinal cells of nematodes. | bioRxiv | 2025 | 37904973 | PubTator, text mining | PubMed |
| GLO1 regulates hepatocellular carcinoma proliferation and migration through the cell cycle pathway. | BMC Cancer | 2024 | 39434012 | PubTator, text mining | PubMed |
| Sanger Sequencing Reveals Novel Variants in GLO-1, ACE, and CBR1 Genes in Patients of Early and Severe Diabetic Nephropathy. | Medicina (Kaunas) | 2024 | 39336582 | PubTator, text mining | PubMed |
| Loss of NAMPT and SIRT2 but not SIRT1 attenuate GLO1 expression and activity in human skeletal muscle. | Redox Biol | 2024 | 39142179 | PubTator, text mining | PubMed |
| Editorial: Liquid biopsy in oncology: opportunity and challenges. | Front Mol Biosci | 2024 | 39135911 | PubTator, text mining | PubMed |
| G2A as a key modulator of carbonyl stress and apoptosis resistance in glucose-loaded cancer cells. | Biochem Biophys Res Commun | 2024 | 39121674 | PubTator, text mining | PubMed |
| Genomic Analysis Identifies Risk Factors in Restless Legs Syndrome. | Ann Neurol | 2024 | 39078117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/papers?page=5